Copyright © 2021 Pharmascimed. All Rights Reserved.
Novo Nordisk
FDA Approval for Novo Nordisk’s haemophilia drug
- February 21, 2019
- 0
Novo Nordisk has received U.S. FDA approval for Esperoct (turoctocog alfa peg, N8-GP) for the treatment of children and adults with haemophilia A. Today's decision permits physicians to prescribe the drug for...
Read more
Abbott and Novo Nordisk strike digital diabetes deal
- February 21, 2019
- 0
Abbott and Novo Nordisk have begun a non-exclusive partnership to provide integrated digital solutions for patients with diabetes requiring insulin. The collaboration enables insulin data to be shared between Novo...
Read more